Gastrointestinal Tolerance of Infant Formula

NCT ID: NCT02322138

Last Updated: 2015-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study objective is to evaluate the gastrointestinal tolerance of infant formula supplemented with prebiotics.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Tolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental 1 Infant Formula

Milk-based infant formula without prebiotics

Group Type EXPERIMENTAL

Experimental 1 Infant Formula

Intervention Type OTHER

Ready to feed infant formula to be fed ad-libitum

Experimental 2 Infant Formula

Milk-based infant formula with prebiotics

Group Type EXPERIMENTAL

Experimental 2 Infant Formula

Intervention Type OTHER

Ready to feed infant formula to be fed ad-libitum

Human Milk-Fed Reference Group

Breast fed infants

Group Type OTHER

Reference Group

Intervention Type OTHER

Breast fed ad libitum

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental 1 Infant Formula

Ready to feed infant formula to be fed ad-libitum

Intervention Type OTHER

Experimental 2 Infant Formula

Ready to feed infant formula to be fed ad-libitum

Intervention Type OTHER

Reference Group

Breast fed ad libitum

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infant is judged to be in good health.
* Infant is a singleton from a full term birth with a gestational age of 37-42 weeks.
* Infant's birth weight was \> 2490 g (\~5 lbs 8 oz.).
* Infant is between 0 and 8 days of age at enrollment.
* Parent(s) confirm their intention to feed their infant the study product (formula-fed infants) or human milk (human milk-fed infants) as the sole source of nutrition for the duration of the study.
* Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study.

Exclusion Criteria

* Adverse maternal, fetal or infant medical history that effects tolerance, growth, and/or development.
* Infants using medications, home remedies, herbal preparations, probiotics or rehydration fluids that might affect GI tolerance.
* Mother intends to use a combination of breast and formula feeding.
* Participation in another study that has not been approved as a concomitant study by AN.
Maximum Eligible Age

8 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Nutrition

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janice Kajzer, MS, RD, LD

Role: STUDY_CHAIR

Abbott Nutrition

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

W.O.M.B Watching Over Mothers and Babies

Tucson, Arizona, United States

Site Status

Clinical Research Advantage/Colorado Springs Health Partners

Colorado Springs, Colorado, United States

Site Status

Norwich Pediatric Group, PC

Norwich, Connecticut, United States

Site Status

SCORE Physician Alliance, LLC

St. Petersburg, Florida, United States

Site Status

Michael W. Simon, M.D., PSC

Nicholasville, Kentucky, United States

Site Status

Women's Clinic of Lincoln, PC.

Lincoln, Nebraska, United States

Site Status

White Oak Family Physicians DBA Asheboro Research Associates

Asheboro, North Carolina, United States

Site Status

Institute of Clinical Research

Mayfield Heights, Ohio, United States

Site Status

The Cleveland Pediatric Research Center, LLC

Middleburg Heights, Ohio, United States

Site Status

Tanner Memorial Clinic

Layton, Utah, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AL14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prebiotic in Preterm Infants
NCT03306316 COMPLETED NA
Probiotic Formula and Infant Growth
NCT01476397 COMPLETED NA